NSF recently acquired Cambium Analytica, an analytical testing company that focuses on natural foods, beverages, and dietary supplements. This acquisition allows NSF to enhance its offerings in a market increasingly driven by consumer interest in health and wellness.
Health-conscious trends have prompted many consumers to view food as medicine. As a result, NSF aims to help producers maintain high-quality and safe products that meet these evolving demands. By bringing Cambium’s expertise in quality assurance and product development into its fold, NSF can offer more comprehensive services.
Statistics show that over 70% of consumers now prioritize health benefits when choosing food products. This shift underscores the need for reliable testing and certification in the natural product sector. With Cambium’s in-process quality assurance and batch release testing integrated into NSF’s existing certification programs, both companies can better address these market needs.
Sarah Krol will lead Cambium as it becomes “Cambium Analytica, an NSF company.” The 69 employees will remain at their Traverse City, Michigan, location, ensuring continuity for their clients.
With this acquisition, NSF is positioning itself to meet the growing demands of a market that values transparency and quality. In fact, industry experts expect the market for natural supplements to reach nearly $300 billion by 2024, further highlighting the importance of robust testing and certification procedures.
For more information on NSF and their new capabilities, check their news release.
